Depotech(depo) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo)

DEPO 7.300

+1.7%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (837)	10/12/1998 7:28:00 PM
From: John McCarthy	Read Replies (1) of 887

John - Thank you for clearing up the difference between solid tumor and lymphoma, and in addition, for pointing out that one population group (tumor) is bigger than the other (lymphoma). Ignoring stock price altogether, I am still stuck with the picture (rightly or wrongly) that if approved, off label use will mushroom to the size it would have been if the drug were approved in the first place. I still have the analysis (somewhere), and ignoring those that had to drop out for whatever reason, for those with depocrypt - survival time was a good 60+ days longer than Metha_BrandX. Well, sorry to bore you with this speculation. Regards, John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next